|
[Related PubMed/MEDLINE]
Total Number of Papers: 11
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: DNX |
| Long Form |
: DaunoXome |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2008 |
Liposomal daunorubicin (Daunoxome) and polyethylated glycol conjugated asparaginase (PEG-ASPA) in children with relapsed and refractory acute lymphoblastic leukemia treated on compassionate basis. |
CR, HSCT, PEG-ASPA, PEG-ASPA |
| 2 |
2008 |
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia. |
AML, CR, DFS, DNR, OS |
| 3 |
2004 |
Advantages of liposomal delivery systems for anthracyclines. |
--- |
| 4 |
2004 |
Cardiac safety of liposomal anthracyclines. |
--- |
| 5 |
2004 |
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials. |
--- |
| 6 |
2004 |
Liposomal anthracycline administration and toxicity management: a nursing perspective. |
--- |
| 7 |
2004 |
Pharmacoeconomics of liposomal anthracycline therapy. |
--- |
| 8 |
2004 |
Role of liposomal anthracyclines in the treatment of multiple myeloma. |
MM, VAD |
| 9 |
2004 |
Use of liposomal anthracyclines in Kaposi's sarcoma. |
BV, KS |
| 10 |
2003 |
Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia. |
AML, CsA, MDR |
| 11 |
1999 |
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance. |
DNR, MDR |
|
A Search Service for Abbreviation / Long Form
